Wedbush Maintains Outperform on National Health Investors, Raises Price Target to $66
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Richard Anderson maintains an Outperform rating on National Health Investors (NHI) and raises the price target from $64 to $66.
March 18, 2024 | 12:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Richard Anderson maintains an Outperform rating on National Health Investors and raises the price target from $64 to $66.
The upgrade in the price target by a reputable analyst suggests a positive outlook on the stock, likely leading to increased investor confidence and potentially a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100